Global Hydroxychloroquine and Chloroquine Market Report and Forecast 2025-2034

Global Hydroxychloroquine and Chloroquine Market Outlook

The global hydroxychloroquine and chloroquine market size attained a value of USD 1.84 million in 2024, driven by its rising application in the treatment of malaria. The market is anticipated to grow at a CAGR of 8.5% during the forecast period of 2025-2034, likely to attain a value of USD 3.85 million by 2034.

Hydroxychloroquine and Chloroquine: Introduction

Hydroxychloroquine and chloroquine are antimalarial medicines that are used to treat malaria. These medicines were frequently used by healthcare professionals during the COVID-19 pandemic as these were showing positive results in treating the virus when no other medicines were working. Other than coronavirus, the increased cases of malaria got these drugs to get popular especially around pandemic. Hydroxychloroquine is generally used in the treatment of autoimmune diseases, such as rheumatoid arthritis and systematic lupus erythematosus.

SLE Hydroxychloroquine helps in enhancing the performance of immune system and reduces inflammation as well. Chloroquine has been in existence from a long time, but it was never given such important before the pandemic. Chloroquine drug is generally used in treating malaria but it protects patients against malaria caused from parasite. It does so by stopping the growth of malarial parasite in the human body.

Global Hydroxychloroquine and Chloroquine Market Analysis

Due to the high demand for hydroxychloroquine and chloroquine drugs, especially during the COVID-19 pandemic, the rate of manufacturing of these drugs has increased in the last few years. Additionally, due to the discovery of these drugs as a potential treatment for coronavirus, there are many research going on to explore the potential of hydroxychloroquine and chloroquine in other medical conditions as well. Owing to the several research still being in process, the governments have put certain safety guidelines over the regulation and consumptions of these drugs, such as no consumption should be performed without a consultation with a healthcare professional. The potential rise in the use of the medication in the treatment of other diseases is anticipated to propel the hydroxychloroquine and chloroquine market expansion.

Global Hydroxychloroquine and Chloroquine Market Segmentations

Market Breakup by Strength

• 100mg

• 200mg

• 250mg

• 500mg

Market Breakup by Grade

• USP Standards Grade

• EP Standards Grade

• Pharmaceutical Standards Grade

• Others

Market Breakup by Dosage Form

• Tablet

• Injectables

Market by Route of Administration

• Oral

• Intravenous

Hydroxychloroquine and Chloroquine Market Breakup by Applications

• Rheumatoid Arthritis

• Malaria

• COVID-19

• Others

Market Breakup by End User

• Hospitals

• Speciality Clinics

• Homecare

• Others

Market Breakup by Distribution Channel

• Hospital Pharmacy

• Retail Pharmacy

• Online Pharmacy

• Others

Market Breakup by Region

• North America

• Europe 

• Asia Pacific 

• Latin America 

• Middle East and Africa

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Global Hydroxychloroquine and Chloroquine Market Overview

The increased demand for the drugs, owing to its application in the treatment of malaria and especially in the treatment of coronavirus, has been primarily driving the demand. There are specific guidelines regarding the usage of hydroxychloroquine and chloroquine by the government as there are multiple research that are being conducted to validate the fact that they might actually be effective in other medical conditions other than malaria and COVID-19. The hydroxychloroquine and chloroquine drug market development has been running steadily but ever since COVID-19 happened, there has been a huge surge in the demand for these drugs in the global market. The global hydroxychloroquine and chloroquine market is expected to grow in coming years as well.

Global Hydroxychloroquine and Chloroquine Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Ipca Laboratories Ltd.

• Zydus Cadila 

• Novartis AG 

• Teva Pharmaceutical Industries Ltd. 

• Bayer AG 

• Rising Pharma Holdings Inc. 

• Abcam plc. 

• Mylan N.V. 

• Abbott Laboratories 

• Artecef B.V. 

• Uniprix Inc. 

• Recipharm

Key Highlights of the Report